Abbott Laboratories

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:11:23 2024-05-30 pm EDT 5-day change 1st Jan Change
101.7 USD +1.01% Intraday chart for Abbott Laboratories -2.27% -7.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
U.S. FDA set to reorganize its food division starting October RE
Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115 MT
Medtronic beats quarterly profit estimates on medical devices strength RE
Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating MT
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit MT
Drugmaker Abbott India posts Q4 profit rise on higher sales RE
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing MT
Abbott Laboratories Announces Retirement of Robert E. Funck, Jr as Executive Vice President, Finance, Effective July 1, 2024 CI
Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee MT
Dexcom's profit beats estimates on strong glucose monitor demand RE
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength RE
Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126 MT
Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating MT
UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept MT
Correction to Health Care Roundup Article DJ
RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating MT
Raymond James Adjusts Abbott Laboratories' Price Target to $124 From $127, Keeps Outperform Rating MT
Health Care Down After Abbott Earnings -- Health Care Roundup DJ
Sector Update: Health Care Stocks Retreating Late Afternoon MT
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET DJ
S&P 500, Nasdaq dip as interest rate concerns, earnings weigh RE
Abbott Laboratories Raises Midpoint of 2024 Guidance After First-Quarter Beat MT
Top Stories at Midday: U.S. Bancorp, Abbott, Citizens Financial, First Horizon, Prologis, ASML, Travelers Report Earnings; Tesla Asks Shareholders Vote on Musk's Compensation; Eli Lilly Sleep Apnea Drug Trials Hit Primary Endpoints MT
News Highlights : Top Company News of the Day - Wednesday at 1 PM ET DJ
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET DJ
Chart Abbott Laboratories
More charts
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
100.7 USD
Average target price
125.4 USD
Spread / Average Target
+24.46%
Consensus
  1. Stock Market
  2. Equities
  3. ABT Stock
  4. News Abbott Laboratories
  5. Abbott Laboratories Raises Midpoint of 2024 Guidance After First-Quarter Beat